Skip to main content

Month: January 2026

Vishay Intertechnology Extends 193 PUR-SI Series of Snap-in Power Aluminum Capacitors With Voltage Ratings of 550 V and 600 V

Space- and Cost-Saving Devices Offer Ripple Current to 3.27 A and Useful Life of 5000 Hours at +105 MALVERN, Pa., Jan. 14, 2026 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today announced that the company has extended its 193 PUR-SI series of miniature snap-in power aluminum electrolytic capacitors with new voltage ratings of 550 V and 600 V. The Vishay BCcomponents devices deliver up to 30 % higher ripple current than standard solutions in similar case sizes and offer a longer useful life. Traditionally, designers have used three 400 V to 450 V capacitors in series, with voltage balancing resistors across each device, to handle DC bus voltages up to 1100 V — an approach that adds design complexity and potential failure points. With their higher voltage ratings up to 600 V, the enhanced 193 PUR-SI series devices...

Continue reading

CoinShares Appoints BDO LLP as Auditor to Support U.S. Listing Strategy

14 January 2026 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares” or the “Group”) (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF), a leading global asset manager specialising in digital assets, today announced that, following resolutions passed at the annual general meeting on 30 May 2025 and at the request of the Directors of the Company, Baker Tilly Channel Islands Limited (“Baker Tilly”) will resign as statutory auditor of the Company. The Board of the Company has approved the appointment of BDO LLP (the “Successor Auditor”), a UK member firm of BDO International, as statutory auditor and independent registered public accounting firm to the Company. The appointment of the Successor Auditor reflects a key step in CoinShares’ strategic expansion into the U.S. market. BDO LLP is registered with the Public Company Accounting...

Continue reading

Toll Brothers Offers Quick Move-in Homes in Riverbend Community in Charleston, South Carolina

Exclusive waterfront community offers stunning Lowcountry charm CHARLESTON, S.C., Jan. 14, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced Riverbend by Toll Brothers, an exclusive community on James Island, South Carolina, is now showcasing luxury quick move-in homes. Located just minutes from historic downtown Charleston and Folly Beach, the homes in Riverbend offer a seamless blend of modern design and classic Lowcountry charm. Riverbend by Toll Brothers features spacious single-family home designs ranging from 2,224 to 3,689+ square feet, priced from $1 million. Homes include open-concept floor plans, gourmet kitchens, covered patios, and spacious primary bedroom suites with spa-like bathrooms. Quick move-in homes by Toll Brothers are already under construction,...

Continue reading

Coastal Joins Tata Consultancy Services (TCS) to Accelerate Salesforce-Led Transformation at Global Scale

Coastal Joins Tata Consultancy Services (TCS)Coastal Joins Tata Consultancy Services (TCS) to Accelerate Salesforce-Led Transformation at Global ScalePalm Coast, FL, Jan. 14, 2026 (GLOBE NEWSWIRE) — Coastal® (formerly known as Coastal Cloud), a leading Salesforce, data, and AI consultancy, today announced the completion of its acquisition by Tata Consultancy Services (TCS). TCS is a global leader in IT services and digital transformation, operating in 46 countries.The acquisition marks a significant milestone for Coastal, expanding its ability to deliver Salesforce and data-led transformation with greater global scale and depth, while maintaining the culture, values, and customer-first approach that have defined the consultancy since its founding in 2012.Coastal’s team of more than 600 North American professionals...

Continue reading

SKYX Announces $4 Million Strategic Investment from Philotimo Fund, LP, Investor in Growing Small-Cap Companies, at $2.00 Per Share in Straight Common with No Warrants

Investment Brings a Total of $14 Million to SKYX in Recent Funding Over the Past 3 Months from Strategic Investors and Long-Term Shareholders as SKYX continues its Market Penetration and Path to Cash Flow Positive MIAMI, Jan. 14, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive smart home platform technology company with over 100 issued and pending patents globally and 60 lighting and home décor websites, with a mission to make homes and buildings become safe, advanced and smart as the new standard, today announced that it has closed a $4 million equity investment from a new institutional fund Philotimo Fund, LP, that invests in growing small-cap companies. The investment was completed at $2.00 per share in straight common stock with no warrants,...

Continue reading

Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilities

Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilitiesAffidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilitiesTHE HAGUE, The Netherlands, Jan. 14, 2026 (GLOBE NEWSWIRE) — Affidea Group, Europe’s leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including oncology, announces the acquisition of a majority stake in LabPoint S.A. from Lindenhofgruppe. LabPoint S.A. is a medical diagnostics laboratory and a recognised player in laboratory medicine, genetics, which, together with Affidea’s capability, will also have integrated pathology and cytology in Switzerland. Founded in 2022 by Lindenhofgruppe, LabPoint has recorded...

Continue reading

Eagle Pharmaceuticals Announces Divestiture of Barhemsys

WOODCLIFF LAKE, N.J., Jan. 14, 2026 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the divestiture of the marketing authorization for Barhemsys (amisulpride) in the U.S. to LXO Group, Paris, France. Barhemsys is used for the treatment of Postoperative Nausea and Vomiting (PONV) alone or with another antiemetic in patients with or without prior prophylaxis. Approved in February 2020 and launched in the U.S. in November 2020, Barhemsys is the only FDA-approved treatment for PONV, addressing a critical need in post-surgical care by offering a targeted, effective option to manage this common complication. “This strategic divestiture reflects Eagle Pharmaceuticals commitment to streamlining its acute care business and maximizing value for our shareholders, while ensuring...

Continue reading

Primech AI’s Hytron Featured in Havas Media Network’s CES 2026 Super Stream, Reaching Global Enterprise Audience

Curated inclusion by Havas Media Network highlights Hytron’s relevance to enterprise automation and U.S. commercial deploymentSuper Stream Day 2 at CES 2026 brings together bold ideas, real-world innovation, and human-centered technology shaping the future of brands and media.The day opens with Greg James, CEO of Havas Media Network North America, setting the stage for conversations on AI, creativity, data, and experience. Leaders from Havas and its partners share candid hot takes and deep dives on AI partnerships, performance marketing, customer experience, production, and connected health.Highlights include the Havas Neurverse Activation on the main stage, plus CES floor tours featuring Primech AI, Flint Paper Battery, Naqi Logic, and AARP AgeTech—showcasing how technology is driving impact across robotics, sustainability,...

Continue reading

Tecomet and Orchid Orthopedic Solutions to Merge

Global medical manufacturing combination expected to expand complementary capabilities, strengthen supply continuity and support long-term growthTecometTecomet is a global leader in the design, development and manufacture of MedTech and Aerospace & Defense products.OrchidOrchid provides solutions for procedures in major MedTech markets in the U.S. and Europe.Woburn, MA, and Mason, MI, Jan. 14, 2026 (GLOBE NEWSWIRE) — Tecomet and Orchid Orthopedic Solutions (“Orchid”) today announced that they have entered into a definitive agreement to merge, bringing together highly complementary capabilities to better serve their global customers, expand reach and support long-term growth. Tecomet is a global leader in the design, development and manufacture of MedTech and Aerospace & Defense products. Orchid provides...

Continue reading

Figure Announces the On-chain Public Equity Network (OPEN) Running on Provenance Blockchain

Figure stock will be the first public equity trading native on public blockchain; BitGo, Jump Trading Group sign on to support NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — Building on the success of over $20 billion in loans originated on public blockchain, Figure has launched the On-Chain Public Equity Network (OPEN), allowing companies to list their equity native on blockchain. Unlike other tokenization efforts, OPEN equities are blockchain registered, not a tokenized version of Depository Trust and Clearing Corporation (DTCC) securities. The equities will trade on a limit order book using Figure’s Alternative Trading System (ATS), opening the door for continuous trading. Shareholders will be able to use Figure’s Democratized Prime, a decentralized finance (DeFi) protocol to borrow against and lend out their stock, disintermediating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.